Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Molecular Pharmacology
|
October 1, 1988
Photoaffinity labeling of opioid delta receptors with an iodinated azido-ligand: [125I][D-Thr2,pN3Phe4,Leu5]enkephalyl-Thr6
P Bochet, C Icard-Liepkalns, F Pasquini, et al.
European Journal of Cell Biology
|
December 1, 1994
Fate of a fluorescent inhibitor of endopeptidase-24.11 using enzyme-expressing MDCK cells. Modification of its cellular processing with a monoclonal antibody
P E Milhiet, M C Giocondi, P Crine, et al.
Cellular Signalling
|
March 21, 2001
Grb2 promotes reinitiation of meiosis in Xenopus oocytes
K Cailliau, E Browaeys-Poly, I Broutin-L'Hermite, et al.
Journal of Neurochemistry
|
July 1, 1999
The cholecystokininB receptor is coupled to two effector pathways through pertussis toxin-sensitive and -insensitive G proteins
B Pommier, S Da Nascimento, S Dumont, et al.
Journal of Medicinal Chemistry
|
December 16, 1997
Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells
B Bellier, I McCort-Tranchepain, B Ducos, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 5, 1999
A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity
D Cussac, M Vidal, C Leprince, et al.
The EMBO Journal
|
March 15, 1994
Solution structure of GAP SH3 domain by 1H NMR and spatial arrangement of essential Ras signaling-involved sequence
Y S Yang, C Garbay, M Duchesne, et al.
Biopolymers
|
October 1, 1991
Comparison of the bis-intercalating complexes formed between either ditercalinium or a flexible analogue and d(CpGpCpG)2 or d(TpTpCpGpCpGpApA)2 minihelices: 1H- and 31P-NMR analyses
J Pothier, M Delepierre, M C Barsi, et al.
Anti-Cancer Drug Design
|
April 1, 1987
DNA bis-intercalators as new anti-tumour agents: modulation of the anti-tumour activity by the linking chain rigidity in the ditercalinium series
C Garbay-Jaureguiberry, P Laugâa, M Delepierre, et al.
Drugs Under Experimental and Clinical Research
|
January 1, 1987
Rational design of bis-intercalating drugs as antitumour agents: importance of rigidity in the linking chain
C Garbay-Jaureguiberry, C Esnault, M Delepierre, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Molecular Pharmacology
|
October 1, 1988
Photoaffinity labeling of opioid delta receptors with an iodinated azido-ligand: [125I][D-Thr2,pN3Phe4,Leu5]enkephalyl-Thr6
P Bochet, C Icard-Liepkalns, F Pasquini, et al.
European Journal of Cell Biology
|
December 1, 1994
Fate of a fluorescent inhibitor of endopeptidase-24.11 using enzyme-expressing MDCK cells. Modification of its cellular processing with a monoclonal antibody
P E Milhiet, M C Giocondi, P Crine, et al.
Cellular Signalling
|
March 21, 2001
Grb2 promotes reinitiation of meiosis in Xenopus oocytes
K Cailliau, E Browaeys-Poly, I Broutin-L'Hermite, et al.
Journal of Neurochemistry
|
July 1, 1999
The cholecystokininB receptor is coupled to two effector pathways through pertussis toxin-sensitive and -insensitive G proteins
B Pommier, S Da Nascimento, S Dumont, et al.
Journal of Medicinal Chemistry
|
December 16, 1997
Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells
B Bellier, I McCort-Tranchepain, B Ducos, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 5, 1999
A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity
D Cussac, M Vidal, C Leprince, et al.
The EMBO Journal
|
March 15, 1994
Solution structure of GAP SH3 domain by 1H NMR and spatial arrangement of essential Ras signaling-involved sequence
Y S Yang, C Garbay, M Duchesne, et al.
Biopolymers
|
October 1, 1991
Comparison of the bis-intercalating complexes formed between either ditercalinium or a flexible analogue and d(CpGpCpG)2 or d(TpTpCpGpCpGpApA)2 minihelices: 1H- and 31P-NMR analyses
J Pothier, M Delepierre, M C Barsi, et al.
Anti-Cancer Drug Design
|
April 1, 1987
DNA bis-intercalators as new anti-tumour agents: modulation of the anti-tumour activity by the linking chain rigidity in the ditercalinium series
C Garbay-Jaureguiberry, P Laugâa, M Delepierre, et al.
Drugs Under Experimental and Clinical Research
|
January 1, 1987
Rational design of bis-intercalating drugs as antitumour agents: importance of rigidity in the linking chain
C Garbay-Jaureguiberry, C Esnault, M Delepierre, et al.
Page
of 9